Development, differentiation and function of TECs require transcriptional master regulator Foxn1. MAP3K14 and IRF8, genes whose mouse orthologues are regulatory targets of Foxn1, have been implicated in MS by genome-wide association studies (GWAS) [98–100]. This evidence concerns the gene FOXN1 and myeloid sarcoma.